Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 2 Influenza Drugs Faced Shortage This Season
April 14, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 14, 2003
- Kissei Licenses Mitiglinide to Choongwae of South Korea
April 14, 2003
- Matsumotokiyoshi's Profit Forecasts Revised Upward by Security Analysts
April 14, 2003
- Chugai to Focus on Proper Use Following Launch of Xeloda
April 14, 2003
- Sugi Pharmacy: Sales, Profits Increase Remarkably
April 14, 2003
- Toho Reorganizes with Kyoso Mirai Group
April 14, 2003
- OTC NEWS IN BRIEF
April 14, 2003
- EPS to Start CRA Dispatch Business
April 14, 2003
- Doctors Strongly Interested in Advanced Medical Devices: Survey
April 14, 2003
- BUSINESS NEWS IN BRIEF
April 14, 2003
- MEDICAL DIVICE NEWS IN BRIEF
April 14, 2003
- CDFS Recommends Designation of Bio-derived Products
April 7, 2003
- Janssen's Sales Top \50 Bil., 4th Double-Digit Growth in 4 Years: President Sekiguchi
April 7, 2003
- Patient Meal Market to Grow 25% by 2007: Report
April 7, 2003
- PRESS SEMINAR
April 7, 2003
- Otsuka Licenses Dry Powder Inhaler from Innovata Biomed
April 7, 2003
- 10% Elderly Copayment Puts Brake on Patient Visits: CareNet Survey
April 7, 2003
- Number of Drugstores Up 34% to 14,673 in 2002: METI Statistics
April 7, 2003
- Generics Will Cut Mevalotin Sales "No More than 10%" Sankyo
April 7, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…